MYDA Advisors »

Protagonist Therapeutics shares owned by MYDA Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by MYDA Advisors from 13F filings

Historical chart of MYDA Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by MYDA Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by MYDA Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0M 12k 87.34
2024-09-30 $450k 10k 45.00

More positions owned by MYDA Advisors

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Core Scientific Call Option (CORZ)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Biohaven Put Option (BHVN)
Unusual Machs Com Shs Call Option (UMAC)
Echostar Corp Cl A (SATS)
Procap Acquisition Corp Shs Cl A (PCAP)
Nlight (LASR)
At&t (T)
Ishares Silver Tr Ishares Call Option (SLV)
Arcutis Biotherapeutics (ARQT)

View all positions for MYDA Advisors

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Invesco
Geode Capital Management
Woodline Partners
Driehaus Capital Management
Henderson Group
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics